Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10907160 Methods for reducing LRRK2 expression

Patent 10907160 was granted and assigned to Ionis Pharmaceuticals on February, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 19 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11873495 Compounds and methods for reducing LRRK2 expression
0
Edits on 12 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 12 Dec, 2023
Edits made to:
Article (+255 characters)
Article

Patent abstract

Provided herein are methods for decreasing LRRK2 mRNA expression. Such methods are useful to ameliorate LRRK2 associated diseases. Such LRRK2 associated diseases include Parkinson's Disease, including non-LRRK2 mediated Parkinson's Disease.

Edits on 9 Oct, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 9 Oct, 2023
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Hien Thuy Zhao0
Holly Kordasiewicz0
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 19 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109071600
Edits on 25 Apr, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 25 Apr, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
109071600
Date of Patent
February 2, 2021
0
Patent Application Number
160639030
Date Filed
January 5, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=109071600
Patent Citations Received
‌
US Patent 11332746 Compounds and methods for reducing LRRK2 expression
0
‌
US Patent 11530411 Methods for reducing LRRK2 expression
0
Patent Primary Examiner
‌
Sean McGarry
0
Edits on 23 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Mar, 2023
Edits on 21 Dec, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Dec, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11530411 Methods for reducing LRRK2 expression
0
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10907160
Edits on 19 May, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 May, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11332746 Compounds and methods for reducing LRRK2 expression
Edits on 9 Feb, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 9 Feb, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10907160 Methods for reducing LRRK2 expression

Infobox
Is a
Patent
Patent
Patent applicant
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10907160
Date of patent
February 2, 2021
Patent application number
16063903
Date Filed
January 5, 2017
Patent primary examiner
‌
Sean McGarry

Find more entities like US Patent 10907160 Methods for reducing LRRK2 expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.